help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santini, F.
Right arrow Articles by Pinchera, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santini, F.
Right arrow Articles by Pinchera, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 6 2825-2830
Copyright © 2003 by The Endocrine Society

Role for Inner Ring Deiodination Preventing Transcutaneous Passage of Thyroxine

Ferruccio Santini, Paolo Vitti, Luca Chiovato, Giovanni Ceccarini, Marco Macchia, Lucia Montanelli, Gianluca Gatti, Veronica Rosellini, Claudia Mammoli, Enio Martino, Inder J. Chopra, Joshua D. Safer, Lewis E. Braverman and Aldo Pinchera

Departments of Endocrinology (F.S., P.V., G.C., L.M., V.R., C.M., E.M., A.P.), Pharmaceutical Sciences (M.M.), and Plastic Surgery (G.G.), University of Pisa, 56124 Pisa, Italy; Endocrinology Unit, University of Pavia, Fondazione Salvatore Maugeri IRCCS (L.C.), Pavia, Italy; Department of Endocrinology, University of California (I.J.C.), Los Angeles, California 90095; and Section of Endocrinology, Boston University School of Medicine (J.D.S., L.E.B.), Boston, Massachusetts 02118

Address all correspondence and requests for reprints to: Dr. Ferruccio Santini, Department of Endocrinology, University of Pisa, Via Paradisa, 2, 56124 Pisa, Italy.

Creams containing thyroid hormone are commonly employed for cosmetic purposes. To verify whether T4 applied to the skin surface can enter the bloodstream either directly or as a metabolite, a cream containing L-T4 [3,5,3',5'-tetraiodothyronine (T4)] was self-applied by volunteers for 2 wk. No significant variations in urinary iodide, TSH, and serum (total and free) T4 and T3 concentrations were observed at any time relative to pretreatment values, whereas rT3 concentrations increased significantly 6 and 12 h after cream application. The increased rT3 concentration led us to investigate the presence of inner ring type III deiodinase (D3) activity in human skin. Using human surgical discard skin, we found that T4 can be carried across human epidermis in a liposome cream. Substantial inner ring deiodination was suggested by the fact that only 10% of transferred thyroid hormone remained as T4, and T3 was not detected. We then measured D3 activity in a surgical skin specimen. The Km for T3 was 1.74 nmol/liter, and the maximum velocity was 23.5 fmol/µg microsomal protein/h. In conclusion, our study indicates that normal human skin serves as a substantial, but incomplete, barrier to T4 passage. D3 plays an important role in augmenting T4 blockade by inactivating T4 to rT3.

Abbreviations: D3, Type III deiodinase; T2, 3,3'-diiodothyronine.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Dentice, C. Luongo, S. Huang, R. Ambrosio, A. Elefante, D. Mirebeau-Prunier, A. M. Zavacki, G. Fenzi, M. Grachtchouk, M. Hutchin, et al.
Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes
PNAS, September 4, 2007; 104(36): 14466 - 14471.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. J. Visser
The elemental importance of sufficient iodine intake: a trace is not enough.
Endocrinology, May 1, 2006; 147(5): 2095 - 2097.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont
Selenium, the Thyroid, and the Endocrine System
Endocr. Rev., December 1, 2005; 26(7): 944 - 984.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Santini, A. Pinchera, A. Marsili, G. Ceccarini, M. G. Castagna, R. Valeriano, M. Giannetti, D. Taddei, R. Centoni, G. Scartabelli, et al.
Lean Body Mass Is a Major Determinant of Levothyroxine Dosage in the Treatment of Thyroid Diseases
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 124 - 127.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society